Nova Patents
ES2979062T3

Insulin formulations comprising polysorbate 80

Abstract

According to the invention there is provided, inter alia, an aqueous liquid pharmaceutical formulation comprising insulin or an insulin analogue, ionic zinc, a chelating agent and polysorbate 80. (Automatic translation with Google Translate, no legal value)

Term

10.6 yearsto projected expiry

Projected expiry 5 May 2037, counted from filing; an application has no term until it is granted.

  1. Priority and filed
  2. Published
  3. Today
  4. Projected expiry

11 members in 6 offices

This recordMember, by publication date

Members11

Family members, oldest first
DocumentOfficeKind
GB201607918D0United KingdomD0
WO2017191464A1World Intellectual Property Organization (WIPO)A1
US2018078645A1United States of AmericaA1
CN109069590AChinaA
EP3452079A1European Patent Office (EPO)A1
US11278624B2United States of AmericaB2
US2022184213A1United States of AmericaA1
EP3452079B1European Patent Office (EPO)B1
EP3452079C0European Patent Office (EPO)C0
ES2979062T3This recordSpainT3
US2025099593A1United States of AmericaA1